These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 18260119)
1. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome in a hematopoietic stem cell transplant recipient. Birch J; Chamlin S; Duerst R; Jacobsohn D Pediatr Blood Cancer; 2008 Jun; 50(6):1278-9. PubMed ID: 18260119 [TBL] [Abstract][Full Text] [Related]
2. Mycoplasma pneumoniae and atypical Stevens-Johnson syndrome: a case series. Ravin KA; Rappaport LD; Zuckerbraun NS; Wadowsky RM; Wald ER; Michaels MM Pediatrics; 2007 Apr; 119(4):e1002-5. PubMed ID: 17353300 [TBL] [Abstract][Full Text] [Related]
3. Mycoplasma pneumoniae-induced recurrent Stevens-Johnson syndrome in children: a case report. Campagna C; Tassinari D; Neri I; Bernardi F Pediatr Dermatol; 2013; 30(5):624-6. PubMed ID: 24016288 [TBL] [Abstract][Full Text] [Related]
4. Severe Mycoplasma pneumoniae-associated mucositis treated with immunoglobulins. Bressan S; Mion T; Andreola B; Bisogno G; Da Dalt L Acta Paediatr; 2011 Nov; 100(11):e238-40. PubMed ID: 21535132 [TBL] [Abstract][Full Text] [Related]
5. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. Abe R J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400 [TBL] [Abstract][Full Text] [Related]
6. Characterization of Children With Recurrent Episodes of Stevens Johnson Syndrome. Olson D; Abbott J; Lin C; Prok L; Dominguez SR J Pediatric Infect Dis Soc; 2017 Sep; 6(3):e140-e143. PubMed ID: 28339562 [TBL] [Abstract][Full Text] [Related]
7. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Tassaneeyakul W; Jantararoungtong T; Chen P; Lin PY; Tiamkao S; Khunarkornsiri U; Chucherd P; Konyoung P; Vannaprasaht S; Choonhakarn C; Pisuttimarn P; Sangviroon A; Tassaneeyakul W Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695 [TBL] [Abstract][Full Text] [Related]
8. Statistical analysis of Stevens-Johnson syndrome caused by Mycoplasma pneumonia infection in Japan. Kunimi Y; Hirata Y; Aihara M; Yamane Y; Ikezawa Z Allergol Int; 2011 Dec; 60(4):525-32. PubMed ID: 22113160 [TBL] [Abstract][Full Text] [Related]
9. [Stevens-Johnson syndrome associated with Mycoplasma pneumoniae infection in an adult]. Iwata M; Tano M; Ikuta N; Inagaki T; Suzuki S; Kondo M; Naito Y; Matsumoto S Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jan; 29(1):89-94. PubMed ID: 2041264 [TBL] [Abstract][Full Text] [Related]
10. Mucositis, conjunctivitis but no rash - the "Atypical Stevens - Johnson syndrome". McGouran DC; Petterson T; McLaren JM; Wolbinski MP Acute Med; 2011; 10(2):81-2. PubMed ID: 22041607 [TBL] [Abstract][Full Text] [Related]
11. Erythema multiforme due to Mycoplasma pneumoniae infection in two children. Schalock PC; Dinulos JG; Pace N; Schwarzenberger K; Wenger JK Pediatr Dermatol; 2006; 23(6):546-55. PubMed ID: 17155996 [TBL] [Abstract][Full Text] [Related]
12. Medications as risk factors of Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a pooled analysis. Levi N; Bastuji-Garin S; Mockenhaupt M; Roujeau JC; Flahault A; Kelly JP; Martin E; Kaufman DW; Maison P Pediatrics; 2009 Feb; 123(2):e297-304. PubMed ID: 19153164 [TBL] [Abstract][Full Text] [Related]
13. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel. Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC; J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772 [TBL] [Abstract][Full Text] [Related]
15. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China. Yang Y; Xu J; Li F; Zhu X Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409 [TBL] [Abstract][Full Text] [Related]
16. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications. Ueta M; Sotozono C; Inatomi T; Kojima K; Hamuro J; Kinoshita S Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811 [TBL] [Abstract][Full Text] [Related]
17. Mycoplasma pneumoniae infection presenting as Stevens-Johnson syndrome: a case report. Sadler JP; Gibson J Dent Update; 1997 Nov; 24(9):367-8. PubMed ID: 9534423 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of treatments and deceased cases of severe adverse drug reactions--analysis of 46 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis]. Yamane Y; Aihara M; Tatewaki S; Matsukura S; Kanbara T; Yamakawa Y; Ikezawa Z Arerugi; 2009 May; 58(5):537-47. PubMed ID: 19487835 [TBL] [Abstract][Full Text] [Related]
20. A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Lonjou C; Borot N; Sekula P; Ledger N; Thomas L; Halevy S; Naldi L; Bouwes-Bavinck JN; Sidoroff A; de Toma C; Schumacher M; Roujeau JC; Hovnanian A; Mockenhaupt M; Pharmacogenet Genomics; 2008 Feb; 18(2):99-107. PubMed ID: 18192896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]